Kinesis Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Chennai, Tamil Nadu, India, established in 1994.
1994 Chennai, Tamil Nadu, India Active
Last Updated:
Access Report
About Kinesis Pharmaceuticals Private Limited

Kinesis Pharmaceuticals Private Limited, a active private limited company, was established on 22 March 1994 in Chennai, Tamil Nadu, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24231TN1994PTC027081. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹2.00 Cr.

It upholds a compliant status. Employing 33 professional, Its leadership includes Olaganathan Meenakshi (Director), Viswanathan Shanmugasundaram (Additional Director), Arumugam Olaganathan (Director). Past directors included Balasubramanian Ravi Sankar, Ananthanarayanan Varadarajan, Arumugam Olaganathan. It holds ₹0.60 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at No.87 & 96 , Mohammed Hussain Colony, Vivekanada Nagar Main Road, Kolathur,, Chennai, Tamil Nadu, 600099.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231TN1994PTC027081

  • Registration Number

    027081

  • Incorporation Date

    22 March 1994

  • Authorized Capital

    ₹5.00 Cr

  • Paid-Up Capital

    ₹2.00 Cr

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 Cr
  • Paid Up Capital ₹ 2.00 Cr
  • Company Age 32 Year, 3 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 0.60 M
  • Revenue Growth **** -15.45%
  • Profit Growth **** -73.73%
  • Ebitda **** -73.85%
  • Net Worth 25.46%
  • Total Assets -34.91%
Company report

Kinesis Pharmaceuticals Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Kinesis Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Kinesis Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Olaganathan Meenakshi Director 27 Jan 2011 Current
Viswanathan Shanmugasundaram Additional Director 01 Aug 2022 Current
Arumugam Olaganathan Director 15 Mar 2010 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 27 Jan 2011 Past
Pramod Abcsdd Director 06 Aug 2012 Past
Pramod Abcsdd Managing Director 02 Aug 2022 Past
Pramod Abcsdd Director 27 Jan 2011 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Kinesis Pharmaceuticals.

Kinesis Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 15.45% decrease. The company also saw a substantial fall in profitability, with a 73.73% decrease in profit. The company's net worth Soared by an impressive increase of 25.46%.

Kinesis Pharmaceuticals revenue growth over time
Kinesis Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -15.45%
*******
*******
*******
*******
Revenue from Operations
*******
 -15.94%
*******
*******
*******
*******
Total Assets
*******
 -34.91%
*******
*******
*******
*******
Profit or Loss
*******
 -73.73%
*******
*******
*******
*******
Net Worth
*******
 25.46%
*******
*******
*******
*******
EBITDA
*******
 -73.85%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Kinesis Pharmaceuticals?

Unlock access to Kinesis Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹600,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • The Vysya Bank Limited : 0.05 Cr
  • Indian Overseas Bank : 0.01 Cr
Latest Charge Details
Date Lender Amount Status
03 Jan 1998 The Vysya Bank Limited ₹0.50 M Open
16 Feb 1995 Indian Overseas Bank ₹0.10 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Kinesis Pharmaceuticals?

Kinesis Pharmaceuticals has a workforce of 33 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Kinesis Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kinesis Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Kinesis Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Kinesis Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Kinesis Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai. was documented.

  • Director Appointment

    The activity Viswanathan Shanmugasundaram was appointed as a Additional Director was appointed as a Additional Director on 01 Aug 2022 & has been associated with this company since 3 years 11 months . was completed.

  • Director Appointment

    Progress on Olaganathan Meenakshi was appointed as a Director was appointed as a Director on 27 Jan 2011 & has been associated with this company since 15 years 5 months . was documented.

  • Director Appointment

    The activity Arumugam Olaganathan was appointed as a Director was appointed as a Director on 15 Mar 2010 & has been associated with this company since 16 years 3 months . was completed.

  • Charges

    A charge with The Vysya Bank Limited of Rs. 0.05 Cr registered on 03 Jan 1998 with Charge ID 90282973 was modified on 05 Jul 2004. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Kinesis Pharmaceuticals Private Limited?

The CIN of Kinesis Pharmaceuticals Private Limited is U24231TN1994PTC027081.

Where is Kinesis Pharmaceuticals Private Limited headquartered?

Kinesis Pharmaceuticals Private Limited is headquartered at No.87 & 96 , Mohammed Hussain Colony, Vivekanada Nagar Main Road, Kolathur,, Chennai, Tamil Nadu, 600099.

When was Kinesis Pharmaceuticals Private Limited incorporated?

Kinesis Pharmaceuticals Private Limited was incorporated on 22 March 1994.

Who are the current directors of Kinesis Pharmaceuticals Private Limited?

The current directors of Kinesis Pharmaceuticals Private Limited are

What is the primary industry of Kinesis Pharmaceuticals Private Limited?

The primary industry of Kinesis Pharmaceuticals Private Limited is Trade.

Is Kinesis Pharmaceuticals Private Limited a listed company?

Kinesis Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Kinesis Pharmaceuticals Private Limited?

The authorized capital of Kinesis Pharmaceuticals Private Limited is ₹5.00 Cr, and the paid-up capital is ₹2.00 Cr.

What is the compliance status of Kinesis Pharmaceuticals Private Limited?

The compliance status of Kinesis Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available